
Lamiwin 500mg Infusion
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Levofloxacin (500mg)
Overview Lamiwin 500mg Infusion
Infuxin 500mg intravenous solution is a bacterial infection treatment antibiotic. Its applications include urinary tract, nasal, throat, cutaneous, soft tissue, and pulmonary (pneumonia) infections. The drug halts pathogen proliferation, thus resolving the infection. Administered intravenously by healthcare providers only, Infuxin 500mg is indicated when oral ingestion is impractical, such as with hospitalized or comatose individuals. Self-administration is strictly prohibited. Complete the prescribed course; do not miss doses even with symptom improvement. Potential side effects include headache, dizziness, nausea, and constipation. While diarrhea is possible, it should subside upon treatment completion; consult a physician if persistent or bloody stools occur. Injection site reactions (pain, swelling, redness) may be temporary, but prolonged symptoms warrant medical attention. This medication is contraindicated for individuals with known allergies to its components. Patients with renal impairment require careful monitoring during treatment.
Uses of Lamiwin 500mg Infusion
Managing Bacterial Infections
Major Benefits of Lamiwin 500mg Infusion:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Lamiwin 500mg Infusion:
- Injection site reactions (pain, swelling, redness)
- Headache
- Dizziness
- Nausea
- Constipation
- Diarrhea
How to use Lamiwin 500mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Lamiwin 500mg Infusion works:
Lamiwin 500mg intravenous solution is a bactericidal antibiotic. Its mechanism of action involves inhibiting bacterial DNA-gyrase, a crucial enzyme for bacterial replication and repair, thus resulting in bacterial cell death.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside a 500mg Lamiwin infusion presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Lamiwin 500mg Infusion during pregnancy poses a confirmed risk to the fetus. Its use should be avoided, except in exceptional, life-threatening circumstances where the potential benefits clearly outweigh the known hazards. Always seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Administering Lamiwin 500mg Infusion while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication's transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Lamiwin 500mg intravenously can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administering Lamiwin 500mg Infusion requires careful consideration. A modified dosage of Lamiwin 500mg Infusion might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 500mg Lamiwin infusions to individuals with hepatic impairment. Physician consultation is advised. Discontinue use and contact your physician immediately if icteric symptoms appear during treatment.
What if you forget to take Lamiwin 500mg Infusion :
Omit a dose of Lamiwin 500mg Infusion? Seek your physician's advice.
Facts to Know About Lamiwin 500mg Infusion
| Label | Value |
|---|---|
| Type of Compound | Quinolone antibiotic |
| Addictive | None. |
| Type of Medication | Antimicrobial Agents |
| Mechanism of Action | Fluoroquinolone antibiotics |
